David MacDonald PhD - President

Dr David MacDonald has an over 25-year record of achievement in drug development and leadership of biotech companies achieving important technical milestones for those businesses and meeting critical corporate objectives.



Beth Cameron PhD - Vice President Clinical Development

Dr. Cameron is a Ph.D. scientist with over 20 years in the drug development industry. She has been at MSI since October 2012.



Dr Steven Targum MD - Chairman, Clinical Advisory Board

Steve Targum JpegDr Targum is widely regarded as an expert in the areas of protocol design, clinical trial methodologies, surveillance strategies, study analysis, and the progression of new drug candidates from concept to approval to launch.